Allphase Pharma Consulting, LLC
A Professional Service Provider for the Pharma Industry
Two posters on tacicepts caught our eyes. First is the Tumlin publication on povetacicept, an oral presentation in the “Late-Breaking Research” session. This is an interim look at Phase 1b study data reporting on 17 IgAN patients treated for 48 weeks with a dose of 80 mg and 30 patients Continue reading TACICEPTS VYING FOR YOUR ATTENTION
Shortly after posting our last blog on tacicepts, new data was published in the NEJM on the pivotal Phase 3 trial of atacicept. This publication by Lafayette et al. provides results from an IA of the ongoing ORIGIN-3 trial.[1] We updated our table with this new information that centers on Continue reading COMPARISON OF BAFF / APRIL INHIBITORS – 2
Francis William Rogers Brambell was an Irish scientist who rose to prominence in the middle of the last century. He is remembered for 2 major accomplishments. First and foremost, his discovery that passive immunity is transferred from mother to baby. Based on research in various animal species on the transfer Continue reading Prof Brambell’s FcRn – The Story So Far